EPISODE · Feb 19, 2026 · 6 MIN
今天3分钟我们来聊聊iNKT免疫疗法：肝肿瘤缩小1/3的希望
from 源于细胞BioInsid的个人播客
2013年肿瘤免疫疗法登顶《Science》突破榜首，成为第五大肿瘤治疗技术。相比传统疗法，iNKT免疫治疗几乎无副作用，疗效持续36周以上，还能与其他疗法联用提升效果。73岁结肠癌肝转移患者接受2次iNKT联合介入治疗后，肿瘤缩小1/3，标志物下降近半，生活如常。前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊iNKT免疫疗法：肝肿瘤缩小1/3的希望
0:00
6:32
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 6 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on February 19, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!